DonorPlex™ Pooled Donor Human Hepatocytes Enable the Next Level of Reliability | Lonza



September 24, 2021

  • Share
  • Watch our expert, Maureen Bunger, PhD, explain how our patented manufacturing process ensures that the DonorPlex™ Hepatocytes exhibit improved phenotype reproducibility. Additionally, we have a proprietary algorithm that predicts yield, viability and functional phenotype prior to manufacture which ensures individual customer specifications are met. Learn more about DonorPlex™ Pooled Donor Human Hepatocytes: Learn how Lonza can support your liver research applications: DonorPlex™ Pooled Donor Human Hepatocytes products from Lonza: #ADME #Toxicology #Drugmetabolism #pharmacokinetic #DrugDiscovery #hepatocytes #primarycells #FDA #Lonza #DrugDrugInteraction #DDI

    Cell CultureDrug Discovery

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.